Calculate your potential ROI with ACT

Tested in over 300 breast health clinics across the US, ACT has proven results across the board(1,2). Input your Total Annual Screenings to estimate the ROI ACT can have at your clinic.

Increase breast cancer screening compliance rates

Improve radiologists’ accuracy, productivity, and workflow

Optimize clinic operations to ensure patients receive timely and compassionate care

Total Annual Screenings

Estimated ROI

0
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
0

This calculation is based on a global average screening reimbursement of $205 and is for estimation purposes only. Actual results will vary.

Footnotes

1. Compared to a previous average of about 1% or less growth per year.
2. Average growth rate across all clinics using ACT.

Customizable. Scaleable. Integrated.

Clinical decision support software for breast cancer risk assessment to expand your comprehensive breast health services.

How It Works

WRRisk serves as a fully digital breast cancer risk assessment combining patient completed digital forms with a density assessment to provide a unified risk scorecard.

The product assigns a risk rating to a patient to drive a digital personalized screening plan for more consistent follow-up recommendations and more accurate diagnosis. This approach helps to catch cancers in the women that are at the greatest risk.

Risk education is critical. Most premenopausal and postmenopausal women with breast cancer have at least one breast cancer risk factor.¹

Risk education is critical. Most premenopausal and postmenopausal women with breast cancer have at least one breast cancer risk factor.¹

Unique Features

WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation.

The product equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime risk as well as risk-based on runner-up density.

WRRisk is built on top of existing well-established models for breast cancer risk.

Find out how our products can help your business increase compliance, increase revenue and improve outcomes.

Request A Demo
Footnotes

1 Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017;3(9):1228–1236.